Tensile Testing Assay for the Measurement of Tissue Stiffness in Arabidopsis Inflorescence Stem

Tensile Testing Assay for the Measurement of Tissue Stiffness in Arabidopsis Inflorescence Stem

Lignocellulosic biomass is a flexible renewable useful resource for fuels, buildings, crafts, and biomaterials. Strategies of molecularly designing lignocellulose for industrial software has been developed by the discoveries of novel genes after the screenings of varied mutants and remodeled traces of Arabidopsis whose cell partitions might be modified in the inflorescence stem, a mannequin woody tissue. The mechanical properties are used as a quantitative index for the chemorehological conduct of the genetically modified cell wall in the tissue.

This parameter could be measured with tensile or bending checks of tissue explants, the vibration evaluation of tissue conduct or utilizing atomic power microscopy to probe the tissue floor. Here, we describe in element the process to find out the stiffness of methanol-fixed, rehydrated and pronase-treated inflorescence explants with a tensile testing machine primarily based on classical strategies for the dedication of cell wall extensibility.

Extracellular matrix (ECM)-based tissue engineering scaffolds have a necessary position in selling tissue regeneration. Nerve tissue engineering goals at facilitating the restore of everlasting injury to the peripheral and central nervous methods, that are tough to heal. For this function, a range of biomaterials are being developed consisting of quite a few artificial and/or pure polymers to offer axonal reinnervation and to direct the development of axons. Here, we current a novel protocol that permits to manufacture a three-d (3D) decellularized scaffold derived from the bovine spinal twine (BSC) ECM (3D-dCBS) for neural tissue engineering purposes.

In this protocol, a viscous ECM-derived gel from BSC is ready, molded, and chemically crosslinked with EDC/NHS (3D-CBS) earlier than decellularization course of. Decellularization of 3D-CBS is carried out with 1% SDS to realize 3D-dCBS. As in contrast with different out there strategies, our protocol is a novel decellularization technique that preserves a extra important half of the ECM. We imagine that the talked about protocol has the potential to supply a bioengineered scaffold from spinal twine tissue with desired geometry for regenerative drugs purposes associated to neural tissue engineering.

The Fabrication of Poly( Σ-caprolactone)-Poly(ethylene oxide) Sandwich Type Nanofibers Containing Sericin-Capped Silver Nanoparticles as an Antibacterial Wound Dressing

In this examine, antibacterial, artificial poly(Σ-caprolactone)-poly(ethylene oxide) (PCL-PEO) multilayer nanofibers had been produced by an electrospinning technique. The materials was synthesized in Three layers. The upper-lower protecting layers had been produced by PCL nanofibers and the intermediate layer was produced from PEO nanofiber containing sericin-capped silver nanoparticles (S-AgNPs). The electrospinning circumstances in which nano-sized, clean, bead-free fibers had been obtained was decided to be an utilized voltage of 20 kV, a circulate price of 8 μL/min and a distance between the collector and the needle tip of 22 cm for the PCL layer (dissolved at a 12% g/mL focus in a chloroform:methanol (3:2) solvent combination) layer.

For the S-AgNPs doped PEO layer (dissolved at a 3.5% g/mL focus in water), the corresponding circumstances had been decided to be 20 kV, 15 μL/min and 20 cm.To characterize the three-layer materials that consisted of PCL and S-AgNPs doped PEO layers, FTIR and SEM analyses had been carried out, and the water retention capability, in situ degradability and antibacterial exercise of the materials was investigated.

According to SEM evaluation, the fibers obtained had been discovered to be nano-sized, clean and bead-free and the common measurement of the nanofibers forming the PCL layer was 687 nm whereas the common measurement of the fibers forming the PEO layer was 98 nm. Antibacterial exercise checks had been carried out utilizing gram-positive (Staphylococcus aureus ATCC 6538) and gram-negative (Escherichia coli ATCC 25922) micro organism and the ensuing biomaterial was discovered to have antimicrobial impact on each gram-negative and gram-positive micro organism. It was decided that the 3-layer materials obtained in this examine can be utilized as a wound dressing.

 Tensile Testing Assay for the Measurement of Tissue Stiffness in Arabidopsis Inflorescence Stem

Peptide-Chitosan Engineered Scaffolds for Biomedical Applications

Peptides are signaling epitopes that management many important organic occasions. Increased specificity, artificial feasibility with concomitant lack of toxicity, and immunogenicity make this rising class of biomolecules appropriate for totally different purposes together with therapeutics, diagnostics, and biomedical engineering. Further, chitosan, a naturally occurring linear polymer composed of d-glucosamine and N-acetyl-d-glucosamine items, possesses anti-microbial, muco-adhesive, and hemostatic properties together with wonderful biocompatibility.

As a end result, chitosan finds software in drug/gene supply, tissue engineering, and bioimaging. Despite these purposes, chitosan demonstrates restricted cell adhesion and lacks biosignaling. Therefore, peptide-chitosan hybrids have emerged as a brand new class of biomaterial with improved biosignaling properties and cell adhesion properties. As a end result, current research embody elevated software of peptide-chitosan hybrids as composites or conjugates in drug supply, cell remedy, and tissue engineering and as anti-microbial materials. This evaluate discusses the current investigations involving chitosan-peptide supplies and uncovers varied facets of these attention-grabbing hybrid supplies for biomedical purposes.

Recombinant (E.Coli) Anti-Tetanus Toxoid scFv IgG

RP-343 10 ug
EUR 286

pHrdSV40- scFv- GCN4- sfGFP- VP64- GB1- NLS

PVT10950 2 ug
EUR 301

Anti-ROR1 (clone R11) scFv-Fc-Sec ADC

ADC-W-434 1mg Ask for price
Description: This ADC product is comprised of an anti-ROR1 scFv-Fc (clone R11) conjugated via a engineered selenocysteine (Sec) residue linker to a drug

Control siRNA Vector (pGB-control)

9500C-20
EUR 338

Recombinant Anti-CTLA4 x Anti-PD1 Bispecific Antibody (IgG-scFv)

IGFV-146 200μg Ask for price
Description: A bispecific antibody that is expressed as a LC and an extended HC with scFv moiety linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, 2+2 antigen-binding valency. This BsAb can bind two factors simultaneously and enhance immune response. It is designed for the research of Tumors therapy.

Recombinant Anti-IL17 x Anti-TNF Bispecific Antibody (IgG-scFv)

IGFV-175 200μg Ask for price
Description: A bispecific antibody that is designed to be expressed as a LC and an extended HC with scFv moiety linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, 2+2 antigen-binding valency. This BsAb can block two proinflammatory cytokines simultaneously. It is designed for the research of Rheumatoid arthritis (RA); Plaque psoriasis therapy.

Recombinant Anti-BCMA x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-020-100ug 100μg
EUR 3560
Description: A bispecific antibody that is expressed as an anti-BCMA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Multiple myeloma (MM) therapy.

Recombinant Anti-BCMA x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-020-50ug 50μg
EUR 2039
Description: A bispecific antibody that is expressed as an anti-BCMA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Multiple myeloma (MM) therapy.

Recombinant Anti-CD123 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-030-100ug 100μg
EUR 3560
Description: A bispecific antibody that is expressed as an anti-CD123 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Acute myelogenous leukemia (AML); Chronic myelogenous leukemia (CML); Plasmacytoid leukemia therapy.

Recombinant Anti-CD123 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-030-50ug 50μg
EUR 2039
Description: A bispecific antibody that is expressed as an anti-CD123 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Acute myelogenous leukemia (AML); Chronic myelogenous leukemia (CML); Plasmacytoid leukemia therapy.

Recombinant Anti-CD19 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-041-100ug 100μg
EUR 3794
Description: A bispecific antibody that is expressed as an anti-CD19 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Leukemia therapy.

Recombinant Anti-CD19 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-041-50ug 50μg
EUR 2156
Description: A bispecific antibody that is expressed as an anti-CD19 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Leukemia therapy.

Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem scFv)

BSFV-046-100ug 100μg
EUR 3560
Description: A bispecific antibody that is expressed as an anti-CD2 scFv fused with an anti-EGFR scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem scFv)

BSFV-046-50ug 50μg
EUR 2039
Description: A bispecific antibody that is expressed as an anti-CD2 scFv fused with an anti-EGFR scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells and is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

Recombinant Anti-CD33 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-066-100ug 100μg
EUR 3560
Description: A bispecific antibody that is expressed as an anti-CD33 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Ulcerative Colitis (UC); Myelodysplastic syndromes (MDS); Gastric cancer therapy.

Recombinant Anti-CD33 x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-066-50ug 50μg
EUR 2039
Description: A bispecific antibody that is expressed as an anti-CD33 scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Ulcerative Colitis (UC); Myelodysplastic syndromes (MDS); Gastric cancer therapy.

Recombinant Anti-CD3 x Anti-CEA Bispecific Antibody (Tandem scFv)

BSFV-072-100ug 100μg
EUR 3560
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-CEA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Colorectal cancer (CRC); Breast cancer; Lung cancer; Gastric cancer therapy.

Recombinant Anti-CD3 x Anti-CEA Bispecific Antibody (Tandem scFv)

BSFV-072-50ug 50μg
EUR 2039
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-CEA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Colorectal cancer (CRC); Breast cancer; Lung cancer; Gastric cancer therapy.

Recombinant Anti-EGFR x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-077-100ug 100μg
EUR 3560
Description: A bispecific antibody that is expressed as an anti-EGFR scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

Recombinant Anti-EGFR x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-077-50ug 50μg
EUR 2039
Description: A bispecific antibody that is expressed as an anti-EGFR scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

Recombinant Anti-EPCAM x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-079-100ug 100μg
EUR 3560
Description: A bispecific antibody that is expressed as an anti-EPCAM scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Solid tumors therapy.

Recombinant Anti-EPCAM x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-079-50ug 50μg
EUR 2039
Description: A bispecific antibody that is expressed as an anti-EPCAM scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Solid tumors therapy.

Recombinant Anti-CD3 x Anti-PSMA Bispecific Antibody (Tandem scFv)

BSFV-102-100ug 100μg
EUR 3560
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-PSMA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Prostate cancer therapy.

Recombinant Anti-CD3 x Anti-PSMA Bispecific Antibody (Tandem scFv)

BSFV-102-50ug 50μg
EUR 2039
Description: A bispecific antibody that is expressed as an anti-CD3 scFv fused with an anti-PSMA scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget T cells to tumor cells. It is designed for the research of Prostate cancer therapy.

Recombinant Anti-FIXa x Anti-FX Bispecific Antibody (Tandem scFv)

BSFV-162-100ug 100μg
EUR 3794
Description: A bispecific antibody that is expressed as an anti-FIXa scFv fused with an anti-FX scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can bind and dimerize two factors. It acts as mimetic FXIII. It is designed for the research of Hemophilia A therapy.

Recombinant Anti-FIXa x Anti-FX Bispecific Antibody (Tandem scFv)

BSFV-162-50ug 50μg
EUR 2156
Description: A bispecific antibody that is expressed as an anti-FIXa scFv fused with an anti-FX scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can bind and dimerize two factors. It acts as mimetic FXIII. It is designed for the research of Hemophilia A therapy.

Recombinant Anti-BSA x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-c001-100ug 100μg
EUR 3794
Description: A bispecific antibody that is expressed as an anti-BSA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can be used as a negative control to other anti-CD3 BsAbs in the research of tumor therapy.

Recombinant Anti-BSA x Anti-CD3 Bispecific Antibody (Tandem scFv)

BSFV-c001-50ug 50μg
EUR 2156
Description: A bispecific antibody that is expressed as an anti-BSA scFv fused with an anti-CD3 scFv, contains a His-tag at the C/N terminus for affinity purification. This BsAb can be used as a negative control to other anti-CD3 BsAbs in the research of tumor therapy.

Quality Control

abx098966-1vial 1 vial
EUR 300

pMD18- Control

PVT10563 2 ug
EUR 266

pMD19- Control

PVT10564 2 ug
EUR 266

Donkey IgG (Control, non-immune, isotype control)

20028-1 1 mg
EUR 164

Rat neurofascin (Nfasc)-control Control/blocking peptide

AB-23249-CP 100ug
EUR 164

Recombinant Anti-CD123 x Anti-CD3 Bispecific Antibody (Fab-scFv-Fc)

FABVC-030-100ug 100μg
EUR 3911
Description: A bispecific antibody that the Fab of anti-CD123 antibody variable domain is fused to the Fc-knob domain with a hinge region and the same as the scFv of anti-CD3 to the Fc-hole domain, or vice versa. This BsAb can retarget T cells to tumor cells. It is designed for the research of Acute myelogenous leukemia (AML); Chronic myelogenous leukemia (CML); Plasmacytoid leukemia therapy.

Recombinant Anti-CD123 x Anti-CD3 Bispecific Antibody (Fab-scFv-Fc)

FABVC-030-50ug 50μg
EUR 2390
Description: A bispecific antibody that the Fab of anti-CD123 antibody variable domain is fused to the Fc-knob domain with a hinge region and the same as the scFv of anti-CD3 to the Fc-hole domain, or vice versa. This BsAb can retarget T cells to tumor cells. It is designed for the research of Acute myelogenous leukemia (AML); Chronic myelogenous leukemia (CML); Plasmacytoid leukemia therapy.

Rat IgG-Biotin conjugate (isotype control) (Isotype control)

20005-B 100 ug
EUR 164

Rat IgG-FITC conjugate (isotype control) (Isotype control)

20005-F 100 ug
EUR 164

Rat IgG-HRP conjugate (isotype control) (Isotype control)

20005-HP 100 ug
EUR 164

Rat IgG-PE conjugate (isotype control) (Isotype control)

20005-PE 25 tests
EUR 202

GFP Lentivirus Control

LTV-300 1 vial
EUR 566
Description: HIV-1 Lentivirus

RFP Lentivirus Control

LTV-301 1 vial
EUR 566
Description: HIV-1 Lentivirus

CHO Control Antigen

F063 50 ul
EUR 219
Description: CHO Control Antigen by Cygnus Technologies is available in Europe via Gentaur.

SF9 Control Antigen

F127 50 ul
EUR 240
Description: SF9 Control Antigen by Cygnus Technologies is available in Europe via Gentaur.

S.cerevisiae Control Antigen

F132 50 ul
EUR 219
Description: S.cerevisiae Control Antigen by Cygnus Technologies is available in Europe via Gentaur.

L.lactis Control Antigen

F497 50 ul
EUR 257
Description: L.lactis Control Antigen by Cygnus Technologies is available in Europe via Gentaur.

PER.C6 Control Antigen

F536 70 ul
EUR 334
Description: PER.C6 Control Antigen by Cygnus Technologies is available in Europe via Gentaur.

Human IgG1 Control

HY-P9900 5mg
EUR 647

CEL-BSA Control

STA-302 100 µg
EUR 322
Description:
  • N-epsilon-(carboxyethyl) lysine (CEL) modified BSA may be used as a positive control. 100 µg at 1 mg/mL in PBS.
  • Provided at 1 mg/mL in 1X PBS

MG-BSA Control

STA-306 100 µg
EUR 322
Description:
  • Methylglyoxal-BSA (MG-BSA) may be used as a positive control. 100 µg at 1 mg/mL in PBS.
  • Provided at 1 mg/mL

CML-BSA Control

STA-314 100 µg
EUR 322
Description:
  • CML-BSA may be used as a positive control. 100 µg.
  • Provided at 1 mg/mL in 1X PBS

MDA-BSA Control

STA-333 100 µg
EUR 322
Description:
  • MDA-BSA (Malondialdehyde-BSA) may be used as a positive control. 100 µg.
  • Provided at 1 mg/mL in 1X PBS

HNE-BSA Control

STA-335 100 µg
EUR 322
Description:
  • HNE-BSA (4-Hydroxynonenal-BSA) may be used as a positive control. 100 µg.
  • Provided at 1 mg/mL in 1X PBS

Goat IgG Control

GT15900 1 mg
EUR 166

Kemptide Negative Control

5-01422 4 x 5mg Ask for price

Rabbit Control IgG

AC005 100 ul
EUR 133

Mouse Control IgG

AC011 100 ul
EUR 133

Rat Control IgG

AC034 100 ul
EUR 133

siRNA Negative Control

20-abx941273
  • EUR 217.00
  • EUR 258.00
  • 2.5 nmol
  • 5 nmol

Rabbit Isotype Control

abx200646-100ug 100 ug
EUR 328

IgG control Antibody

abx234182-100ug 100 ug
EUR 481

Amyloid (Control Slides)

TCS0003-100 100 Slides
EUR 706

Amyloid (Control Slides)

TCS0003-25 25 Slides
EUR 232

Amyloid (Control Slides)

TCS0003-5 5 Slides
EUR 98

Argentaffin (Control Slides)

TCS0004-100 100 Slides
EUR 706

Argentaffin (Control Slides)

TCS0004-25 25 Slides
EUR 232

Argentaffin (Control Slides)

TCS0004-5 5 Slides
EUR 98

Fungus (Control Slides)

TCS0005-100 100 Slides
EUR 706

Fungus (Control Slides)

TCS0005-25 25 Slides
EUR 232

Fungus (Control Slides)

TCS0005-5 5 Slides
EUR 98

Bielschowsky's (Control Slides)

TCS0006-100 100 Slides
EUR 706

Bielschowsky's (Control Slides)

TCS0006-25 25 Slides
EUR 232

Bielschowsky's (Control Slides)

TCS0006-5 5 Slides
EUR 98

Calcium (Control Slides)

TCS0007-100 100 Slides
EUR 706

Calcium (Control Slides)

TCS0007-25 25 Slides
EUR 232

Calcium (Control Slides)

TCS0007-5 5 Slides
EUR 98

Elastic (Control Slides)

TCS0008-100 100 Slides
EUR 706

Elastic (Control Slides)

TCS0008-25 25 Slides
EUR 232

Elastic (Control Slides)

TCS0008-5 5 Slides
EUR 98

Melanin (Control Slides)

TCS0015-100 100 Slides
EUR 706

Melanin (Control Slides)

TCS0015-25 25 Slides
EUR 232

Melanin (Control Slides)

TCS0015-5 5 Slides
EUR 98

Mucin (Control Slides)

TCS0016-100 100 Slides
EUR 706

Mucin (Control Slides)

TCS0016-25 25 Slides
EUR 232

Mucin (Control Slides)

TCS0016-5 5 Slides
EUR 98

Reticulum (Control Slides)

TCS0019-100 100 Slides
EUR 706

Reticulum (Control Slides)

TCS0019-25 25 Slides
EUR 232

Reticulum (Control Slides)

TCS0019-5 5 Slides
EUR 98

Compstatin control peptide

B5478-1 1 mg
EUR 373

Mouse IgG1 Control

ICIGG1A-50 50 µg
EUR 323

Mouse IgG1 Control

ICIGG1AC750-50 50 µg
EUR 713

Mouse IgG1 Control

ICIGG1CFB-100 100 µg
EUR 323

Mouse IgG1 Control

ICIGG1F-100 100 µg
EUR 199.5

Mouse IgG1 Control

ICIGG1PE-50 50 µg
EUR 323

Mouse IgG1 Control

ICIGG1PP-100 100 µg
EUR 323

Mouse IgG1 Control

ICIGG1PP5.5-100 100 µg
EUR 323

Mouse IgG1 Control

ICIGG1PU-100 100 µg
EUR 199.5

Mouse IgG2a Control

ICIGG2AA-50 50 µg
EUR 323

Mouse IgG2a Control

ICIGG2AB-100 100 µg
EUR 199.5

Mouse IgG2a Control

ICIGG2ACFB-100 100 µg
EUR 323

Mouse IgG2a Control

ICIGG2AF-100 100 µg
EUR 199.5

Mouse IgG2a Control

ICIGG2APE-50 50 µg
EUR 323

Mouse IgG2a Control

ICIGG2APP-100 100 µg
EUR 323

Mouse IgG2a Control

ICIGG2APP5.5-100 100 µg
EUR 323

Mouse IgG2a Control

ICIGG2APU-100 100 µg
EUR 199.5

Mouse IgG2b Control

ICIGG2BA-50 50 µg
EUR 323

Mouse IgG2b Control

ICIGG2BCFB-100 100 µg
EUR 323

Mouse IgG2b Control

ICIGG2BF-100 100 µg
EUR 199.5

Mouse IgG2b Control

ICIGG2BPE-50 50 µg
EUR 323

Mouse IgG2b Control

ICIGG2BPP-100 100 µg
EUR 323

Mouse IgG2b Control

ICIGG2BPP5.5-100 100 µg
EUR 323

Mouse IgG2b Control

ICIGG2BPU-100 100 µg
EUR 199.5

Mouse IgG3 Control

ICIGG3A-50 100 µg
EUR 648

Mouse IgG3 Control

ICIGG3CFB-100 100 µg
EUR 388

Mouse IgG3 Control

ICIGG3F-100 100 µg
EUR 323

Mouse IgG3 Control

ICIGG3PE-50 50 µg
EUR 518

Mouse IgG3 Control

ICIGG3PU-100 100 µg
EUR 323

Mouse IgM Control

ICIGMF-100 100 µg
EUR 199.5

Mouse IgM Control

ICIGMPU-100 100 µg
EUR 199.5

Rabbit Isotype Control

IMN-001 100 µg
EUR 199.5

TRAF6 Control Peptide

H-7606.0001 1.0mg
EUR 506
Description: Sum Formula: C139H232N34O42; CAS# [852690-80-3] net

Hemoglobin A1c control

35R-AH001 1 ml
EUR 256
Description: Hemoglobin A1c control

Mouse IgG Control

10R-I169A 250 ug
EUR 127
Description: Mouse Immunoglobulins Mouse IgG Control

Cytotoxicity Control (saponin)

Z5030008 50 mg
EUR 249
Description: Premade ready to use kits will always come in handy. Get your experiment done right form the first try by using a validated kit with perfectly balanced reagents proportions and compatibility and by following a clear protocol.

Goat IgG control

31R-AG001 1 mg
EUR 127
Description: Goat Immunoglobulins Goat IgG control

Rabbit IgG Control

31R-AR001 500 ug
EUR 133
Description: Purified Normal Rabbit IgG

pGL3- Control Plasmid

PVT1306 2 ug
EUR 266

IgG control antibody

PAab09882 100 ug
EUR 386

Control Magnetic Beads

M1302-1 Ask for price

FMK Negative Control

1122-100
EUR 175

FMK Negative Control

1122-20C
EUR 175

Goat IgG (-ve control for flow cytometry) (isotype control)

20011-100 100 test
EUR 103

Llama IgG (Control, non-immune, isotype control, ELISA grade)

20030-1 1 mg
EUR 164

Camel IgG (Control, non-immune, isotype control, ELISA grade)

20031-1 1 mg
EUR 164

Alpaca IgG (Control, non-immune, isotype control, ELISA grade)

20032-1 1 mg
EUR 164

Mouse Lipin-1 Control/blocking peptide control/blocking peptide #1

LPN11-P 100 ug
EUR 164

Due to the lack of vascular distribution and the sluggish metabolism, cartilage tissue can’t restore itself, which stays an enormous problem for cartilage regeneration. Tissue engineering utilizing stem cells seems to be a promising technique for cartilage restore. Tissue engineers demonstrated that mechanical stimulation can improve the high quality of engineered cartilage, making it extra much like pure cartilage in construction and performance. In this evaluate, we summarize current research on the position of mechanical stimuli in chondrogenesis, specializing in the purposes of extrinsic mechanical loading and the research on mechanical properties of biomaterials in cartilage tissue engineering. This evaluate will present contemporary insights into the potential use of mechanical stimuli for scientific use.


A Review on the Design and Hydration Properties of Natural Polymer-Based Hydrogels

A Review on the Design and Hydration Properties of Natural Polymer-Based Hydrogels

Hydrogels are hydrophilic 3D networks which might be capable of ingest massive quantities of water or organic fluids, and are potential candidates for biosensors, drug supply vectors, vitality harvester gadgets, and carriers or matrices for cells in tissue engineering. Natural polymers, e.g., cellulose, chitosan and starch, have glorious properties that afford fabrication of superior hydrogel supplies for biomedical functions: biodegradability, biocompatibility, non-toxicity, hydrophilicity, thermal and chemical stability, and the excessive capability for swelling induced by facile artificial modification, amongst different physicochemical properties.

Hydrogels require variable time to succeed in an equilibrium swelling as a result of the variable diffusion charges of water sorption, capillary motion, and different modalities. In this examine, the nature, transport kinetics, and the function of water in the formation and structural stability of numerous varieties of hydrogels comprised of pure polymers are reviewed.Since water is an integral half of hydrogels that represent a substantive portion of its composition, there’s a must receive an improved understanding of the function of hydration in the construction, diploma of swelling and the mechanical stability of such biomaterial hydrogels.

The capability of the polymer chains to swell in an aqueous solvent will be expressed by the rubber elasticity concept and different thermodynamic contributions; whereas the charge of water diffusion will be pushed both by focus gradient or chemical potential. An overview of fabrication methods for numerous varieties of hydrogels is offered in addition to their responsiveness to exterior stimuli, together with their potential utility in numerous and novel functions. This overview goals to shed gentle on the function of hydration to the construction and perform of hydrogels. In flip, this overview will additional contribute to the improvement of superior supplies, reminiscent of “injectable hydrogels” and super-adsorbents for functions in the subject of environmental science and biomedicine.

Formation of contractile 3D bovine muscle tissue for development of millimetre-thick cultured steak

Owing to the enhance in the international demand of meat, cultured meat expertise is being developed to bypass a scarcity of meat in the future. However, strategies for development of millimetre-thick bovine muscle tissues with extremely aligned myotubes haven’t but been established. Here, we suggest a tradition technique for establishing 3D-cultured bovine muscle tissue containing myotubes aligned alongside its long-axial course, which contracted in response to electrical stimulation.

First, we optimised the composition of biomaterials utilized in the development and the electrical stimulation utilized to the tissue throughout tradition. Subsequently, we fabricated millimetre-thick bovine muscle tissues containing extremely aligned myotubes by accumulating bovine myoblast-laden hydrogel modules. The microbial content material of the bovine muscle tissue cultured for 14 days was beneath the detection restrict, indicating that the muscle tissues have been sterile, not like business meat. Therefore, the proposed development technique for bovine muscle tissues can be helpful for the manufacturing of clear cultured steak meat simulating actual meat.

The synergistic union of nanomaterials with biomaterials has revolutionized artificial chemistry, enabling the creation of nanomaterial-based biohybrids with distinct properties for biomedical functions. This class of supplies has drawn vital scientific curiosity from the perspective of purposeful extension by way of controllable coupling of artificial and biomaterial parts, leading to enhancement of the chemical, bodily, and organic properties of the obtained biohybrids.

In this overview, we spotlight the forefront supplies for the mixture with biomacromolecules and residing organisms and their advantageous properties in addition to latest advances in the rational design and synthesis of synthetic biohybrids. We additional illustrate the unbelievable variety of biomedical functions stemming from artificially bioaugmented traits of the nanomaterial-based biohybrids. Eventually, we intention to encourage scientists with the software horizons of the thrilling subject of artificial augmented biohybrids.

A Review on the Design and Hydration Properties of Natural Polymer-Based Hydrogels

Current Insights Into 3D Bioprinting: An Advanced Approach for Eye Tissue Regeneration

Three-dimensional (3D) printing is a recreation changer expertise that holds nice promise for all kinds of biomedical functions, together with ophthalmology. Through this rising method, particular eye tissues will be custom-fabricated in a versatile and automated method, incorporating completely different cell varieties and biomaterials in exact anatomical 3D geometries. However, and regardless of the nice progress and prospects generated lately, there are nonetheless challenges to beat that jeopardize its scientific software in common apply. The predominant aim of this overview is to offer an in-depth understanding of the present standing and implementation of 3D bioprinting expertise in the ophthalmology subject in an effort to manufacture related tissues reminiscent of cornea, retina and conjunctiva.

Goat IgG-PE conjugate (isotype control)

20011-PE 100 tests
EUR 225

Rat IgG-Biotin conjugate (isotype control) (Isotype control)

20005-B 100 ug
EUR 164

Rat IgG-FITC conjugate (isotype control) (Isotype control)

20005-F 100 ug
EUR 164

Rat IgG-HRP conjugate (isotype control) (Isotype control)

20005-HP 100 ug
EUR 164

Rat IgG-PE conjugate (isotype control) (Isotype control)

20005-PE 25 tests
EUR 202

Goat IgG (fc)-Biotin conjugate (isotype control)

20011-Fc-B 100 ug
EUR 164

Goat IgG (fc)-FITC conjugate (isotype control)

20011-Fc-F 100 ug
EUR 164

Goat IgG (fc)-HRP conjugate (isotype control)

20011-Fc-HP 100 ug
EUR 164

Goat F(ab')2 IgG Isotype Control

abx405076-05mg 0.5 mg
EUR 411

Rabbit IgG Isotype Control

abx125003-100ul 100 ul
EUR 203

Rabbit IgG Isotype Control

IC001-100ul 100ul
EUR 122

Mouse IgG Isotype Control

IC002-100ul 100ul
EUR 122

IgG Isotype Control antibody

10R-6524 50 ug
EUR 133
Description: Armenian Hamster monoclonal IgG Isotype Control antibody

IgG Isotype Control antibody

10R-6525 50 ug
EUR 133
Description: Syrian Hamster monoclonal IgG Isotype Control antibody

Rat IgG Isotype Control

31-AR15 10 mg
EUR 220
Description: Purified Rat IgG Isotype Control

Goat IgG (-ve control for flow cytometry) (isotype control)

20011-100 100 test
EUR 103

Goat IgG, purified (serum non-immune, isotype control)

20011-1 1 mg
EUR 141

Goat IgG, purified (serum non-immune, isotype control)

20011-25 25 mg
EUR 469

Goat IgG, purified (serum non-immune, isotype control)

20011-5 5 mg
EUR 286

Goat F(ab')2 IgG Isotype Control (FITC)

abx405077-100tests 100 tests
EUR 495

Goat F(ab')2 IgG Isotype Control (RPE)

abx405078-05ml 0.5 ml
EUR 537

Rat IgG purified (isotype control)

20005-1-200 0.5 ml
EUR 103

Rat IgG, purified (Isotype control)

20005-5 5 mg
EUR 286

Sheep IgG, purified (isotype control)

20006-1 1 mg
EUR 141

Rabbit IgG-biotinylated (isotype control)

20009-BT-1 1 mg
EUR 286

Hamster (Armenian) IgG Isotype Control

abx405028-025mg 0.25 mg
EUR 384

Hamster (Arnenian) IgG Isotype Control

abx405029-05mg 0.5 mg
EUR 592

Hamster (Syrian) IgG Isotype Control

abx405032-025mg 0.25 mg
EUR 384

Syrian Hamster IgG Isotype Control

SIGGA-100 100 µg
EUR 574.16

Syrian Hamster IgG Isotype Control

SIGGB-200 200 µg
EUR 472.24

Syrian Hamster IgG Isotype Control

SIGGF-200 200 µg
EUR 545.04

Syrian Hamster IgG Isotype Control

SIGGPE-100 100 µg
EUR 515.92

Syrian Hamster IgG Isotype Control

SIGGPP5.5-100 100 µg
EUR 676.08

Syrian Hamster IgG Isotype Control

SIGGPP5.5-25 25 µg
EUR 355.76

Syrian Hamster IgG Isotype Control

SIGGPU-500 500 µg
EUR 428.56

Rabbit IgG Isotype control, Concentrate

NG910C 0.5 ml
EUR 392

Armenian Hamster IgG Isotype control

AIGGA-100 100 µg
EUR 574.16

Armenian Hamster IgG Isotype control

AIGGA-25 25 µg
EUR 282.96

Armenian Hamster IgG Isotype control

AIGGB-200 200 µg
EUR 472.24

Armenian Hamster IgG Isotype control

AIGGB-50 50 µg
EUR 239.28

Armenian Hamster IgG Isotype control

AIGGF-200 200 µg
EUR 545.04

Armenian Hamster IgG Isotype control

AIGGF-50 50 µg
EUR 268.4

Armenian Hamster IgG Isotype control

AIGGPE-100 100 µg
EUR 515.92

Armenian Hamster IgG Isotype control

AIGGPE-25 25 µg
EUR 253.84

Armenian Hamster IgG Isotype control

AIGGPP-100 100 µg
EUR 574.16

Armenian Hamster IgG Isotype control

AIGGPP-25 25 µg
EUR 268.4

Armenian Hamster IgG Isotype control

AIGGPP5.5-100 100 µg
EUR 646.96

Armenian Hamster IgG Isotype control

AIGGPP5.5-25 25 µg
EUR 282.96

Armenian Hamster IgG Isotype control

AIGGPU-50 50 µg
EUR 195.6

Armenian Hamster IgG Isotype control

AIGGPU-500 500 µg
EUR 428.56

FITC Rabbit IgG - Isotype control

DB1000 100 tests
EUR 422

FITC Rabbit IgG - Isotype control

DB-1000 100 tests
EUR 422

IgG Isotype Control antibody (FITC)

61R-1136 50 ug
EUR 165
Description: Armenian Hamster monoclonal IgG Isotype Control antibody (FITC)

IgG Isotype Control antibody (PE)

61R-1337 200 ug
EUR 440
Description: Armenian Hamster monoclonal IgG Isotype Control antibody (PE)

IgG Isotype Control antibody (PE)

61R-1338 50 ug
EUR 181
Description: Syrian Hamster monoclonal IgG Isotype Control antibody (PE)

IgG Isotype Control antibody (biotin)

61R-1586 50 ug
EUR 165
Description: Armenian Hamster monoclonal IgG Isotype Control antibody (biotin)

IgG Isotype Control antibody (biotin)

61R-1587 50 ug
EUR 165
Description: Syrian Hamster monoclonal IgG Isotype Control antibody (biotin)

IgG Isotype Control antibody (allophycocyanin)

61R-1768 100 ug
EUR 349
Description: Armenian Hamster monoclonal IgG Isotype Control antibody (allophycocyanin)

IgG Isotype Control antibody (allophycocyanin)

61R-1769 50 ug
EUR 219
Description: Syrian Hamster monoclonal IgG Isotype Control antibody (allophycocyanin)

IgG Isotype Control antibody (FITC)

61R-1800 25 ug
EUR 205
Description: Rabbit polyclonal IgG Isotype Control antibody (FITC)

Donkey IgG (Control, non-immune, isotype control)

20028-1 1 mg
EUR 164

Goat IgG Control

GT15900 1 mg
EUR 166

Goat IgG control

31R-AG001 1 mg
EUR 127
Description: Goat Immunoglobulins Goat IgG control

Rabbit IgG Isotype Control APC Conjugate

APCCON 0.15 mg
EUR 261

Rabbit IgG Isotype Control FITC Conjugate

FITCCON 0.15 mg
EUR 261

Mouse IgG Isotype Control PerCP Conjugate

MPERCPCON 0.15 mg
EUR 261

Mouse IgG Isotype Control RPE Conjugate

MRPECON 0.15 mg
EUR 261

Rabbit IgG Isotype Control PerCP Conjugate

PERCPCON 0.15 mg
EUR 261

Rabbit IgG Isotype Control RPE Conjugate

RPECON 0.15 mg
EUR 261

Mouse IgG Isotype Control APC Conjugate

MAPCCON 0.15 mg
EUR 261

Mouse IgG Isotype Control FITC Conjugate

MFITCCON 0.15 mg
EUR 261

Hamster IgG, purified (Syrian, isotype control)

20003-1 1 mg
EUR 141

Hamster IgG, purified (Armenian, Isotype control)

20003-1AH 1 mg
EUR 263

Human IgG-HRP Conjugate (isotype control)

20007-1-HP 500 ug
EUR 202

Mouse IgG-Biotin conjugate (isotype control)

20008-B 50 Tests
EUR 164

Mouse IgG-Biotin conjugate (isotype control)

20008-BT-1 1 mg
EUR 164

Mouse IgG-FITC conjugate (isotype control)

20008-F 100 tests
EUR 164

Mouse IgG-HRP conjugate (isotype control)

20008-HP 50 Tests
EUR 164

Mouse IgG-PE conjugate (isotype control)

20008-PE 50 Tests
EUR 164

Rabbit IgG-FITC conjugate (isotype control)

20009-F 100 ug
EUR 164

Rabbit IgG-HRP conjugate (isotype control)

20009-HP 100 ug
EUR 164

Rabbit IgG-PE conjugate (isotype control)

20009-PE 100 tests
EUR 225

Hamster (Arnenian) IgG Isotype Control (FITC)

abx405030-01mg 0.1 mg
EUR 384

Hamster (Arnenian) IgG Isotype Control (RPE)

abx405031-01mg 0.1 mg
EUR 509

Hamster (Syrian) IgG Isotype Control (FITC)

abx405033-01mg 0.1 mg
EUR 398

Donkey IgG (non-immune, isotype control) IgG, purified

20015-10 10 mg
EUR 286

Llama IgG (Control, non-immune, isotype control, ELISA grade)

20030-1 1 mg
EUR 164

Camel IgG (Control, non-immune, isotype control, ELISA grade)

20031-1 1 mg
EUR 164

Alpaca IgG (Control, non-immune, isotype control, ELISA grade)

20032-1 1 mg
EUR 164

Goat IgG Control Sera

20011-250 0.5 ml
EUR 103

Hamster IgG-Biotin conjugate, isotype control (Syrian)

20003-1-B 100 test
EUR 164

Hamster IgG-Cy5 conjugate, isotype control (Syrian)

20003-1-Cy5 50 tests
EUR 225

Hamster IgG-FITC conjugate, isotype control (Syrian)

20003-1-F 100 tests
EUR 164

Hamster IgG-HRP conjugate, isotype control (Syrian)

20003-1-HP 100 tests
EUR 164

G. Pig IgG-Biotin conjugate (isotype control)

20004-B 100 ug
EUR 202

G. Pig IgG-FITC conjugate (isotype control)

20004-F 100 ug
EUR 202

G. Pig IgG-HRP conjugate (isotype control)

20004-HP 100 ug
EUR 202

Rat IgG Fab fragment, purified (isotype control)

20005-1-FAB 1 mg
EUR 164

Rat IgG (Fc) fragment, purified (isotype control)

20005-1-FC 0.5 mg
EUR 250

Human IgG-Fc fragment purified (isotype control)

20007-F100 100 ug
EUR 141

Human IgG-Fc fragment purified (isotype control)

20007-F1000 1 mg
EUR 347

Mouse IgG Fab-Biotin conjugate (isotype control)

20008-Fab-B 100 ug
EUR 164

Mouse IgG Fab-FITC conjugate (isotype control)

20008-Fab-F 100 ug
EUR 164

Mouse IgG Fab-HRP conjugate (isotype control)

20008-Fab-HP 100 ug
EUR 164

Chimpanzee IgG (non-immune, isotype control), purified

20012-Ch-1 1 mg
EUR 225

Donkey IgG (non-immune, isotype control), purified

20015-1 1 mg
EUR 141

Dog IgG (isotype control, non-immune), purified

20016-1 1 mg
EUR 141

Baboon IgG (non-immune, isotype control), purified

20118-1 1 mg
EUR 202

Baboon IgG (non-immune, isotype control), purified

20118-10 10 mg
EUR 895

Bat IgG (non-immune, isotype control), purified

20121-1 25 ug
EUR 286

Mouse IgG Isotype control; Ready-To-Use

NG903 7 ml
EUR 241

IgG Isotype Control Fc fusion protein (FITC)

35R-0013 50 ug
EUR 165
Description: Syrian Hamster monoclonal IgG Isotype Control Fc fusion protein (FITC)

Special consideration is paid to the description of the mostly employed bioprinting strategies, and the most related eye tissue engineering research carried out by 3D bioprinting expertise at preclinical stage. In addition, different related points associated to make use of of 3D bioprinting for ocular drug supply, in addition to each moral and regulatory points, are analyzed. Through this overview, we intention to lift consciousness amongst the analysis neighborhood and report latest advances and future instructions in an effort to apply this superior remedy in the eye tissue regeneration subject.


Development of a Biomimetic Hydrogel Based on Predifferentiated Mesenchymal Stem-Cell-Derived ECM for Cartilage Tissue Engineering

Development of a Biomimetic Hydrogel Based on Predifferentiated Mesenchymal Stem-Cell-Derived ECM for Cartilage Tissue Engineering

The use of decellularized extracellular matrix (dECM) as a biomaterial has been an vital step ahead for the event of purposeful tissue constructs. In addition to tissues and organs, cell cultures are gaining a lot of consideration as a substitute supply of dECM. In this work, a novel biomimetic hydrogel is developed primarily based on dECM obtained from mesenchymal stem cells (mdECM) for cartilage tissue engineering. To this finish, cells are seeded underneath particular tradition situations to generate an early chondrogenic extracellular matrix (ECM) offering cues and components essential for cartilage improvement.

The composition is decided by quantitative, histological, and mass spectrometry methods. Moreover, the decellularization course of is evaluated by measuring the DNA content material and compositional analyses, and the hydrogel is formulated at completely different concentrations (3% and 6% w/v). Results present that mdECM derived hydrogels possess glorious biocompatibility and appropriate physicochemical and mechanical properties for their injectability. Furthermore, it’s evidenced that this hydrogel is ready to induce chondrogenesis of mesenchymal stem cells (MSCs) with out supplemental components and, moreover, to kind hyaline cartilage-like tissue after in vivo implantation. These findings exhibit for the primary time the potential of this hydrogel primarily based on mdECM for functions in cartilage restore and regeneration.

Manufacturing macroscale cell-laden architectures is one of the most important challenges confronted these days within the area of tissue engineering. Such dwelling constructs, in reality, pose strict necessities for vitamins and oxygen provide that may hardly be addressed by means of easy diffusion in vitro or with out a purposeful vasculature in vivo. In this context, within the final twenty years, a substantial quantity of work has been carried out to develop sensible supplies that might actively present oxygen-release to distinction native hypoxia in large-size constructs.

This evaluation offers an summary of the at the moment obtainable oxygen-releasing supplies and their synthesis and mechanism of motion, highlighting their capacities underneath in vitro tissue cultures and in vivo contexts. Additionally, we additionally showcase an rising idea, herein termed as “dwelling supplies as releasing techniques”, which depends on the mixture of biomaterials with photosynthetic microorganisms, particularly algae, in an “unconventional” try to produce the broken or re-growing tissue with the required provide of oxygen.

Prionace glauca pores and skin collagen bioengineered constructs as a promising strategy to set off cartilage regeneration

Representing a technique of marine by-products valorization, primarily based on isolation of biocompounds and evaluation of biomedical applicability, the potential of blue shark (Prionace glauca (PG)) pores and skin collagen to induce chondrogenic differentiation of human adipose stem cells (hASC) was investigated, with and with out exogenous stimulation. For that, a cryogelation methodology was utilized to supply extremely interconnected porous three-d (3D) constructs made of collagen and collagen:hyaluronic acid (20:1). In vitro research reveal that hASC adhere abundantly to the constructs which then suggests the early chondrogenic differentiation of these cells.

These findings are supported by the mRNA expression encoding chondrogenic-related markers like Coll II and Sox-9 which can be markedly upregulated at an early stage for each situations, with and with out exogenous stimulation. The introduction of hyaluronic acid (Hya) appears to play a essential function at later time factors, as proven by the evident immunodetection of aggrecan (ACAN), even with out exogenous stimulation. It is hypothesized that the PG collagen itself can help chondrogenic differentiation at early time factors, however exogenous stimulation is required to make sure phenotype upkeep. The current work highlights the relevance of utilizing blue shark collagen biopolymer as a constructing block to supply extremely efficient short-term matrices for cartilage functions.

 Development of a Biomimetic Hydrogel Based on Predifferentiated Mesenchymal Stem-Cell-Derived ECM for Cartilage Tissue Engineering

L-histidine controls the hydroxyapatite mineralization with plate-like morphology: Effect of focus and media

Hydroxyapatite (HA) is the principle inorganic element of bone and dentin, and their non-stoichiometric compositions and plate-shaped morphology is accountable for their bioactivity and osteoconductive nature. Collagenous (CPs) and non-collagenous proteins (NCPs) facilitate mineralization and regulate structural properties of HA by means of their side-chains. The bioactivity of artificial HA doesn’t often match with the HA present in bone and, subsequently, there may be a want to know the function of biomolecules in bone mineralization with the intention to develop non-stoichiometric plate-shaped HA for bone grafts. Role of a number of amino acids has been investigated however the function of L-his has been not often investigated underneath physiological situations although it’s a half of HA inhibitor proteins, like albumin, amelogenin, and histidine-rich proteins.

Rat IgG2b Isotype Control

RIGG2BF-50 50 µg
EUR 151.92

Rat IgG2b Isotype Control

RIGG2BPE-100 100 µg
EUR 268.4

Rat IgG2b Isotype Control

RIGG2BPE-25 25 µg
EUR 151.92

Rat IgG2b Isotype Control

RIGG2BPP-100 100 µg
EUR 574.16

Rat IgG2b Isotype Control

RIGG2BPP-25 25 µg
EUR 268.4

Rat IgG2b Isotype Control

RIGG2BPP5.5-100 100 µg
EUR 515.92

Rat IgG2b Isotype Control

RIGG2BPP5.5-25 25 µg
EUR 282.96

Rat IgG2b Isotype Control

RIGG2BPU-50 50 µg
EUR 122.8

Rat IgG2b Isotype Control

RIGG2BPU-500 500 µg
EUR 370.32

Rat IgG2b Isotype Control

31R-IC001 500 ug
EUR 241
Description: Purified Rat IgG2b Isotype Control

Rat IgG2b unconjugated (isotype control)

20005-13 100 ug
EUR 164

Rat IgG2b Isotype Control Purified

11-169-C100 0.1 mg
EUR 136

Rat IgG2b Isotype Control FITC

1F-169-C025 0.025 mg
EUR 108

Rat IgG2b Isotype Control FITC

1F-169-C100 0.1 mg
EUR 177

Rat IgG2b Isotype Control (APC)

abx405049-100tests 100 tests
EUR 425

Rat IgG2b Isotype Control (Biotin)

abx405050-01mg 0.1 mg
EUR 314

Rat IgG2b Isotype Control (FITC)

abx405052-01mg 0.1 mg
EUR 342

Rat IgG2b Isotype Control (RPE)

abx405055-100tests 100 tests
EUR 356

Mouse IgG2b Isotype Control

abx139006-01mg 0.1 mg
EUR 314

Mouse IgG2b Isotype Control

abx139011-01mg 0.1 mg
EUR 314

Mouse IgG2b Isotype Control

abx405056-100tests 100 tests
EUR 411

Mouse IgG2b Isotype Control

abx405061-1mg 1 mg
EUR 1080

Mouse IgG2b Isotype Control

abx200580-100ug 100 ug
EUR 314

Rat IgG2b-Biotin conjugate (isotype control)

20005-13-B 100 ug
EUR 202

Rat IgG2b-FITC conjugate (isotype control)

20005-13-F 100 ug
EUR 225

Rat IgG2b-HRP conjugate (isotype control)

20005-13-HP 100 ug
EUR 202

Rat IgG2b Isotype Control LOW ENDOTOXIN

12-169-C100 0.1 mg
EUR 136

Rat IgG2b Isotype Control (Pacific Blue)

abx405054-100tests 100 tests
EUR 384

Mouse IgG2b Isotype Control PerCP

PC-692-C025 0.025 mg
EUR 122

Mouse IgG2b Isotype Control PerCP

PC-692-C100 0.1 mg
EUR 204

Mouse IgG2b isotype control, purified

20102-103 100 ug
EUR 141

Mouse IgG2b Isotype Control Purified

11-692-C025 0.025 mg
EUR 88

Mouse IgG2b Isotype Control Purified

11-692-C100 0.1 mg
EUR 136

Mouse IgG2b Isotype Control Purified

11-801-C025 0.025 mg
EUR 88

Mouse IgG2b Isotype Control Purified

11-801-C100 0.1 mg
EUR 136

Mouse IgG2b Isotype Control APC

1A-692-C025 0.025 mg
EUR 122

Mouse IgG2b Isotype Control APC

1A-692-C100 0.1 mg
EUR 204

Mouse IgG2b Isotype Control Biotin

1B-692-C025 0.025 mg
EUR 108

Mouse IgG2b Isotype Control Biotin

1B-692-C100 0.1 mg
EUR 177

Mouse IgG2b Isotype Control FITC

1F-692-C025 0.025 mg
EUR 108

Mouse IgG2b Isotype Control FITC

1F-692-C100 0.1 mg
EUR 177

Mouse IgG2b Isotype Control PE

1P-692-C025 0.025 mg
EUR 122

Mouse IgG2b Isotype Control PE

1P-692-C100 0.1 mg
EUR 204

Mouse IgG2b Isotype Control (Biotin)

abx139018-01mg 0.1 mg
EUR 384

Mouse IgG2b Isotype Control (PE)

abx139020-01mg 0.1 mg
EUR 425

Mouse IgG2b Isotype Control (APC)

abx139017-01mg 0.1 mg
EUR 425

Mouse IgG2b Isotype Control (FITC)

abx139019-01mg 0.1 mg
EUR 384

Mouse IgG2b Isotype Control (PerCP)

abx139021-01mg 0.1 mg
EUR 425

Mouse IgG2b Isotype Control (APC)

abx405057-100tests 100 tests
EUR 481

Mouse IgG2b Isotype Control (Biotin)

abx405058-100tests 100 tests
EUR 411

Mouse IgG2b Isotype Control (FITC)

abx405059-100tests 100 tests
EUR 411

Mouse IgG2b Isotype Control (RPE)

abx405060-100tests 100 tests
EUR 467

Mouse IgG2b Isotype Control (FITC)

abx200581-100ug 100 ug
EUR 314

Mouse IgG2b Isotype Control (PE)

abx200582-50ug 50 ug
EUR 425

Mouse IgG2b Isotype Control (APC)

abx200583-50ug 50 ug
EUR 425

Mouse IgG2b Isotype Control (PerCP)

abx200584-100ug 100 ug
EUR 425

Mouse IgG2b Isotype control; Concentrate

NG907C 1 ml
EUR 357

Mouse IgG2b-FITC (isotype control)

MG2bF-100 100 Tests
EUR 408

Rat IgG2b-R-PE conjugate (isotype control)

20005-13-PE 25 tests
EUR 202

Mouse IgG2b Isotype Control PE-Cy5

T8-692-C025 0.025 mg
EUR 136

Mouse IgG2b Isotype Control PE-Cy5

T8-692-C100 0.1 mg
EUR 231

Mouse IgG2b Isotype Control PerCP-Cy5.5

T9-692-C025 0.025 mg
EUR 170

Mouse IgG2b Isotype Control PerCP-Cy5.5

T9-692-C100 0.1 mg
EUR 300

Mouse IgG2b-Biotin conjugate (isotype control)

20102-103-B 50 Tests
EUR 164

Mouse IgG2b-FITC conjugate (isotype control)

20102-103-F 50 tests
EUR 164

Mouse IgG2b-HRP conjugate (isotype control)

20102-103-HP 50 Tests
EUR 164

Mouse IgG2b-PE conjugate (isotype control)

20102-103-PE